Li Junmin
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS) Myelodysplastic Syndromes, P53 Mutation | Phase 3 | 2018-03-20 |
| Unknown | Decitabine,Cytarabine and Arsenic Trioxide for Acute Myeloid Leukemia With p53 Mutations Acute Myeloid Leukemia, P53 Mutation | Phase 2 | 2018-03-01 |